Search by Drug Name or NDC

    NDC 76420-0228-18 Tizanidine 2 mg/1 Details

    Tizanidine 2 mg/1

    Tizanidine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Asclemed USA, Inc.. The primary component is TIZANIDINE HYDROCHLORIDE.

    Product Information

    NDC 76420-0228
    Product ID 76420-228_0e7fc7ed-8e8f-3778-e063-6294a90aecb7
    Associated GPIs
    GCN Sequence Number 027447
    GCN Sequence Number Description tizanidine HCl TABLET 2 MG ORAL
    HIC3 H6H
    HIC3 Description SKELETAL MUSCLE RELAXANTS
    GCN 14690
    HICL Sequence Number 011582
    HICL Sequence Number Description TIZANIDINE HCL
    Brand/Generic Generic
    Proprietary Name Tizanidine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tizanidine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2
    Active Ingredient Units mg/1
    Substance Name TIZANIDINE HYDROCHLORIDE
    Labeler Name Asclemed USA, Inc.
    Pharmaceutical Class Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076286
    Listing Certified Through 2025-12-31

    Package

    NDC 76420-0228-18 (76420022818)

    NDC Package Code 76420-228-18
    Billing NDC 76420022818
    Package 180 TABLET in 1 BOTTLE (76420-228-18)
    Marketing Start Date 2023-10-30
    NDC Exclude Flag N
    Pricing Information N/A